Centrexion Therapeutics Corp

Home » Centrexion Therapeutics Corp

IPO

Centrexion Therapeutics Corp

We are a late clinical-stage biopharmaceutical company focused on becoming the leader in identifying, developing and commercializing novel, non-opioid and non-addictive therapies to address the large unmet medical need for the treatment of chronic pain.

Symbol

CNTX

Price Range
$14.00 - $16.00

Final Shares
5,000,000

Anticipated Date
TBD

Underwriters
BofA Merrill Lynch, Leerink Partners, Evercore ISI

To view the prospectus for Centrexion Therapeutics Corp IPO, or any offering listed on ClickIPO,
download the ClickIPO app...

or a prospectus can be requested from G. Price at
ClickIPO Securities, LLC 8601 N Scottsdale Rd, Suite 335, Scottsdale, AZ 85253